Clinical Trials Directory

Trials / Completed

CompletedNCT00963443

Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold

A Double Blind, Placebo-controlled, Parallel Group Study to Evaluate the Efficacy and Safety of Acetylsalicylic Acid Combined With Pseudoephedrine, Compared With Acetylsalicylic Acid Alone, and Pseudoephedrine Alone, on Symptoms of Pain.

Status
Completed
Phase
Phase 3
Study type
Interventional
Enrollment
833 (actual)
Sponsor
Bayer · Industry
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of the study is to determine the effectiveness of an acetylsalicylic acid (aspirin) pseudoephedrine combination for the treatment of pain and congestion symptoms compared to the effectiveness of the individual components of the medicine and the placebo (dummy treatment that looks like the real thing).The combination product of acetylsalicylic acid / pseudoephedrine is already marketed in several European countries as Aspirin® Complex.

Conditions

Interventions

TypeNameDescription
DRUGAcetylsalicylic Acid (Aspirin, BAYE4465)2 Sachets of 500 mg Aspirin Complex.
DRUGPseudoephedrine2 Sachets of 30 mg Pseudoephedrine
DRUGPlaceboMatching Placebo

Timeline

Start date
2009-09-01
Primary completion
2012-03-01
Completion
2012-03-01
First posted
2009-08-21
Last updated
2014-12-05

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT00963443. Inclusion in this directory is not an endorsement.

Acetylsalicylic Acid Combined With Pseudoephedrine in Common Cold (NCT00963443) · Clinical Trials Directory